These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 16734621)
1. Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Harboe M; Garred P; Borgen MS; Stahl GL; Roos A; Mollnes TE Clin Exp Immunol; 2006 Jun; 144(3):512-20. PubMed ID: 16734621 [TBL] [Abstract][Full Text] [Related]
2. The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification. Harboe M; Garred P; Karlstrøm E; Lindstad JK; Stahl GL; Mollnes TE Mol Immunol; 2009 Dec; 47(2-3):373-80. PubMed ID: 19800125 [TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the lectin pathway of complement in human serum. Roos A; Bouwman LH; Munoz J; Zuiverloon T; Faber-Krol MC; Fallaux-van den Houten FC; Klar-Mohamad N; Hack CE; Tilanus MG; Daha MR Mol Immunol; 2003 Jan; 39(11):655-68. PubMed ID: 12493641 [TBL] [Abstract][Full Text] [Related]
4. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. Selander B; Mårtensson U; Weintraub A; Holmström E; Matsushita M; Thiel S; Jensenius JC; Truedsson L; Sjöholm AG J Clin Invest; 2006 May; 116(5):1425-34. PubMed ID: 16670774 [TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Roos A; Garred P; Wildenberg ME; Lynch NJ; Munoz JR; Zuiverloon TC; Bouwman LH; Schlagwein N; Fallaux van den Houten FC; Faber-Krol MC; Madsen HO; Schwaeble WJ; Matsushita M; Fujita T; Daha MR Eur J Immunol; 2004 Sep; 34(9):2589-98. PubMed ID: 15307191 [TBL] [Abstract][Full Text] [Related]
6. Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway. Tateishi K; Matsushita M Microbiol Immunol; 2011 Nov; 55(11):817-21. PubMed ID: 21831201 [TBL] [Abstract][Full Text] [Related]
7. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205 [TBL] [Abstract][Full Text] [Related]
8. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis. Windbichler M; Echtenacher B; Hehlgans T; Jensenius JC; Schwaeble W; Männel DN Infect Immun; 2004 Sep; 72(9):5247-52. PubMed ID: 15322019 [TBL] [Abstract][Full Text] [Related]
10. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176 [TBL] [Abstract][Full Text] [Related]
12. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin. Inoshita H; Matsushita M; Koide S; Kusaba G; Ishii M; Onda K; Gi MJ; Nakata M; Ohsawa I; Horikoshi S; Ohi H; Tomino Y J Immunol Methods; 2009 Sep; 349(1-2):9-17. PubMed ID: 19699205 [TBL] [Abstract][Full Text] [Related]
13. Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement. Rajagopalan R; Nyaundi T; Salvi VP; Rawal N Mol Immunol; 2010 Sep; 47(15):2505-14. PubMed ID: 20579738 [TBL] [Abstract][Full Text] [Related]
14. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism. Ambrosio AR; De Messias-Reason IJ Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991 [TBL] [Abstract][Full Text] [Related]
15. An assay for the mannan-binding lectin pathway of complement activation. Petersen SV; Thiel S; Jensen L; Steffensen R; Jensenius JC J Immunol Methods; 2001 Nov; 257(1-2):107-16. PubMed ID: 11687244 [TBL] [Abstract][Full Text] [Related]
16. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Brouwer N; Dolman KM; van Zwieten R; Nieuwenhuys E; Hart M; Aarden LA; Roos D; Kuijpers TW Mol Immunol; 2006 May; 43(13):2051-60. PubMed ID: 16499969 [TBL] [Abstract][Full Text] [Related]
17. Plasma-derived mannose-binding lectin shows a direct interaction with C1-inhibitor. Keizer MP; Kamp AM; Brouwer N; van de Wetering MD; Wouters D; Kuijpers TW Mol Immunol; 2014 Apr; 58(2):187-93. PubMed ID: 24368318 [TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans. Held K; Thiel S; Loos M; Petry F Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286 [TBL] [Abstract][Full Text] [Related]
19. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Thiel S; Møller-Kristensen M; Jensen L; Jensenius JC Immunobiology; 2002 Sep; 205(4-5):446-54. PubMed ID: 12396006 [TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanisms of allergen-induced activation of the classical and lectin pathways of complement. Varga L; Szilágyi K; Lõrincz Z; Berrens L; Thiel S; Závodszky P; Daha MR; Thielens NM; Arlaud GJ; Nagy K; Späth P; Füst G Mol Immunol; 2003 May; 39(14):839-46. PubMed ID: 12686499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]